FMP

FMP

Enter

ELV - Elevance Health...

photo-url-https://images.financialmodelingprep.com/symbol/ELV.png

Elevance Health Inc.

ELV

NYSE

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

391.35 USD

2.125 (0.543%)

Historical Prices

From:

To:

380382384386388390391.2509:30 AM09:42 AM09:54 AM10:06 AM10:18 AM10:30 AM10:42 AM10:54 AM11:06 AM11:18 AM11:30 AM11:43 AM11:56 AM12:08 PM12:21 PM12:33 PM12:47 PM12:59 PM01:13 PM01:25 PM01:37 PM

About

ceo

Ms. Gail Koziara Boudreaux

sector

Healthcare

industry

Medical - Healthcare Plans

exchange

NYSE

Description

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

CIK

0001156039

ISIN

US0367521038

CUSIP

036752103

Address

220 Virginia Avenue

Phone

800 331 1476

Country

US

Employee

104,900

IPO Date

Oct 30, 2001

Financial Statement

010B20B30B40B50B2023 Q32023 Q42024 Q12024 Q22024 Q3RevenueNet Income

Earnings

0246810122023 Q12023 Q22023 Q32023 Q42024 Q12024 Q22024 Q32024 Q4EPS Consensus

ELV Financial Summary

CIK

0001156039

Exchange

NYSE

Industry

Medical - Healthcare...

Sector

Healthcare

CUSIP

036752103

ISIN

US0367521038

Country

US

Price

391.35

Beta

0.85

Volume Avg.

1.89M

Market Cap

90.76B

Shares

-

52-Week

362.21-567.26

DCF

1.1k

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

14.24

P/B

-

Website

https://www.elevancehealth.com

Upgrades and Downgrades

We are unable to load the data!

fmp-logo

Latest ELV News

businesswire.com

a day ago

Mark Farrah Associates Delves into Acquisition Impacts Utili...

CANONSBURG, Pa.--(BUSINESS WIRE)--MFA reviewed Elevance Health's acquisition of Indiana University Health Plans using Medicare Benefits Analyzer and County Health Coverage.

zacks.com

2 days ago

Elevance Health Q4 Countdown: Smart Move to Buy or Stick Wit...

ELV's fourth-quarter earnings are likely to have benefited from growing premiums, partially offset by higher expenses.

zacks.com

5 days ago

Unveiling Elevance Health (ELV) Q4 Outlook: Wall Street Esti...

Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Elevance Health (ELV), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024.

businesswire.com

Jan 9, 2025

Elevance Health to Hold Conference Call and Webcast to Discu...

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release fourth quarter and full year 2024 financial results on January 23, 2025, at 6:00 a.m. Eastern Standard Time (“EST”). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 – Access Code - 3972058 (Domestic) 312-470-0178 – Access Code - 3972058 (Inte.

seekingalpha.com

Jan 2, 2025

My Top 15 High Growth Dividend Stocks For January 2025

The SPDR S&P 500 ETF Trust ended 2024 on a sour note, losing 2.41% in December and finishing the year up 24.89%. The Top 15 dividend growth stocks for January 2025 offer an average dividend yield of 1.21% and appear to be about 27% undervalued based on dividend yield theory. Since its inception in September 2020, the watch list has achieved a 10.33% compound annual growth rate.

seekingalpha.com

Dec 26, 2024

Elevance Health Is An Undervalued Healthcare Juggernaut

Elevance Health is a strong buy despite a 30% stock decline, due to its solid fundamentals and market position in the health insurance industry. The company benefits from secular trends like an aging population and increased life expectancy, driving long-term demand for healthcare services. Key risks include rising healthcare costs and a shrinking Medicaid member base, impacting margins and free cash flow.

Stuart Mooney

Dec 24, 2024

Electrovaya Inc. (NASDAQ: ELVA) Quarterly Earnings and Finan...

Electrovaya Inc. (NASDAQ: ELVA) is a key player in the lithium-ion battery technology and manufacturing industry. The company is known for its innovative solutions and has been actively expanding its market presence. Electrovaya's competitors include other battery manufacturers and technology firms focusing on energy storage solutions. The company is set to release its quarterly earnings on December 31, 2024. Wall Street anticipates ELVA's earnings per share to be a loss of $0.01, with projecte...

zacks.com

Dec 20, 2024

Elevance Health Stock Plunges 29.6% in Q4: Buy, Hold or Sell...

ELV is reallocating resources to more profitable areas and making prudent acquisitions.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep